Lancaster

This trial is looking at a new drug called camizestrant for early breast cancer that has a medium to high risk of coming back.

This trial is looking at erdafitinib on its own or in combination with cetrelimab for bladder cancer that has spread into or through the muscle layer of the bla

This trial is comparing datopotamab deruxtecan and durvalumab with pembrolizumab and standard chemotherapy before surgery for breast cancer.

This trial is looking at bone marrow samples to help work out the best treatment for myeloma.

This study is to learn more about mesothelioma and how it develops after exposure to asbestos.

This study is looking at a personalised treatment plan. It is for people with HER2 positive early breast cancer.

This trial is looking at the need to treat the lymph glands in the armpit after having chemotherapy followed by surgery for breast cancer.

This trial is looking at adding hydroxychloroquine to chemotherapy for people with small cell lung cancer that has spread.

This study is looking at circulating tumour cells to see if it can help doctors decide when to change treatment for prostate cancer.

This study is to see if women who only have a very small risk of their breast cancer returning need to have radiotherapy after surgery.